Navigation Links
Olanzapine Long-Acting Injection (LAI) Shown to Maintain Treatment Benefit in Schizophrenia for up to Six Months
Date:9/2/2008

tients who have shown an initial treatment response. It is also indicated for the treatment of moderate to severe manic episodes and, in those patients whose manic episode has responded to olanzapine treatment, it is indicated for the prevention of recurrence in patients with bipolar disorder.

SAFETY INFORMATION

Hyperglycaemia and/or development or exacerbation of diabetes occasionally associated with ketoacidosis or coma has been reported rarely, including some fatal cases. In some cases, a prior increase in body weight has been reported, which may be a predisposing factor. Appropriate clinical monitoring is advisable, particularly in diabetic patients and in patients with risk factors for diabetes mellitus for which regular glucose control is recommended.

Undesirable alterations in lipids have been observed in olanzapine-treated patients in placebo-controlled clinical trials. Mean increases in fasting lipid values (total cholesterol, LDL cholesterol, and triglycerides) were greater in patients without evidence of lipid dysregulation at baseline. Lipid alterations should be managed as clinically appropriate, particularly in dyslipidemic patients and in patients with risk factors for the development of lipids disorders.

The proportion of patients who had adverse, clinically significant changes in weight gain, glucose, total/LDL/HDL cholesterol or triglycerides increased over time. In adult patients who completed 9-12 months of therapy, the rate of increase in mean blood glucose slowed after approximately 4-6 months.

As with all antipsychotic medications, a rare and potentially fatal condition known as Neuroleptic Malignant Syndrome (NMS) has been reported rarely with olanzapine. If signs and symptoms appear, immediate discontinuation is recommended. Clinical manifestations of NMS are hyperpyrexia, muscle rigidity, altered mental status and evidence of autonomic instability (irregular pulse or blood pressure, tachycardia, diaphoresi
'/>"/>

SOURCE Eli Lilly and Company
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Olanzapine Long-Acting Injection (LAI) Data Presented at First Annual Schizophrenia International Research Society Conference
2. Forest and Almirall Announce Positive Results of Clinical Studies for Aclidinium Bromide, a Novel, Long-Acting Anticholinergic for the Treatment for COPD
3. Patients Treated with Risperidone Long-Acting Injection had a Significantly Longer Time to Relapse Compared to Quetiapine in International Clinical Study
4. FDA Advisory Committee Supports Efficacy and Safety of Zyprexa(R) Long-Acting Injection (LAI) for Schizophrenia Treatment
5. New England Journal of Medicine Publishes Phase III Results of VELCADE(R) (Bortezomib) for Injection in Previously Untreated Multiple Myeloma Patients
6. New Survey Explores the Impact of Insulin Injections and Communications Between Patients and Healthcare Providers
7. BRIDION(R) (sugammadex) Injection - First and Only Selective Relaxant Binding Agent - Approved in European Union
8. New Diabetes Compound AVE0010 Showed Clear Dose Response Results With Once-A-Day Injection in Phase IIb Study
9. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
10. Multiple Clinical Trials of VELCADE(R) (Bortezomib) for Injection Based Therapies Demonstrate High Complete Remission Rates in Patients with Newly Diagnosed Multiple Myeloma
11. VELCADE(R) (Bortezomib) for Injection Based Treatment Delivers Impressive Complete Response and Survival in Patients With Newly Diagnosed Multiple Myeloma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)...  Lannett Company, Inc. (NYSE: LCI ) today ... Genuity 35th Annual Growth Conference on Wednesday, August 12, ... Hotel.  A webcast of the presentation ... encouraged to visit the web site at least 10 ... register, download and install any necessary software.  The presentation ...
(Date:7/30/2015)... 30, 2015  Cleave Biosciences today announced that ... granted the company a key patent providing the ... CB-5083. This newly issued patent, "Fused ... U.S. 9,062,026, allows for claims on the composition ... oral inhibitor of p97, a critical enzyme that ...
(Date:7/30/2015)... , July 30, 2015 Flexpoint Ford, a ... services sectors, today announced that it has entered into ... Bryan Stuart to form Kastle Therapeutics, LLC (Kastle).  ... , will focus on acquiring, developing and commercializing pharmaceuticals ... acquisition opportunities include select therapies already approved for marketing, ...
Breaking Medicine Technology:Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 2Flexpoint Ford Announces Partnership with Alan MacKenzie and Bryan Stuart to Form Kastle Therapeutics 3
(Date:7/30/2015)... ... 30, 2015 , ... The connection between a healthy head of hair and a feeling of ... full head of hair can have a devastating impact on the daily life of a ... work place, the consequences of hair loss are not to be taken lightly. , The ...
(Date:7/30/2015)... ... 30, 2015 , ... In a meaningful ritual intended to symbolize a final ... Center have created an addiction graveyard. Sharing this with the public comes at a ... Rocky Hudson . Hudson (1945-2015) fell in love with the desert when he moved ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Telemedicine Association (ATA) ... Tradeshow focused exclusively on telemedicine, telehealth and mHealth. The meeting, expected to attract ... take place May 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting attracts ...
(Date:7/30/2015)... , ... July 30, 2015 , ... ... monthly Biz Report, which takes a look at small, medium, and large businesses ... a business expert, conducted the business review and shared with viewers how DevExpress ...
(Date:7/30/2015)... ... July 30, 2015 , ... ... video, “Beachside Nursing Center,” to announce its position as one of Medicare’s ... administrator and staff members support the CMS rating system, which monitors health ...
Breaking Medicine News(10 mins):Health News:New Study Shows the Link between Hair Restoration and Healthy Self-Image 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:Beachside Nursing Center Releases New Video 2
... ... Times, hundreds of people taking the type-2 diabetes drug Avandia® suffer heart attacks and ... Law firm. , ... (PRWEB) February 26, 2010 -- Maher Law Firm attorneys are investigating possible Avandia® ...
... , ... ... ... ...
... the pain and suffering experienced by women being treated for ... Buffalo School of Social Work professor. , The randomized trial ... constant pain among 124 women with metastatic breast cancer, according ... Social Work, a faculty member in the Buffalo Center for ...
... Study found they showed lower brain activity when on ... News) -- Reduced brain activity may explain why drivers ... report. , They used functional MRI to monitor brain ... using a driving simulator. When they were learning the ...
... , ... eve of its twelfth anniversary Connecticut Governor M. Jodi Rell honored Mountainside Addiction Treatment ... the state. , ... Canaan, CT (PRWEB) February 26, 2010 -- On the eve of its twelfth ...
... mussels, clams and can cause paralysis, scientists say , ... tide" this spring and summer could threaten the New ... Maine Toxicity project. , An abundant cyst population in ... bloom of the toxic algae Alexandrium fundyense . ...
Cached Medicine News:Health News:Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia 2Health News:Maher Law Firm Warns Avandia Users - NY Times Reports - FDA Recommends Recall of Avandia 3Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 2Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 3Health News:National Alliance for Hispanic Health Urges Action on Insurance Access as First Step to Achieving Best Health Outcomes for All 4Health News:Hypnosis can help control pain among women with metastatic breast cancer, UB Researcher finds 2Health News:Connecticut Governor Jodi Rell Honors Mountainside Addiction Treatment Center for its Twelve Years of Operating in Connecticut 2Health News:Connecticut Governor Jodi Rell Honors Mountainside Addiction Treatment Center for its Twelve Years of Operating in Connecticut 3Health News:Predicted 'Red Tide' Could Make Shellfish a Dangerous Dish 2
... Nephroscope, with a stainless steel shaft, combines ... lumbotome, for precise pre-cutting of scar tissue, ... access. The 13.5 Fr. oval working channel ... and lithotripsy probes, and allows a high ...
... Pro Resectoscope is based on the award ... enables the surgeon to perform TURis - ... working element, HF cable and electrodes, Olympus ... resection in saline, supporting both, standard TUR ...
... internal drainage from the ureteropelvic junction to ... for ease of placement and patient compliance. ... for repositioning and ease of removal. AQ® ... that when activated, attracts and holds water ...
... a PC-based ECG device that can ... and an innovative software. The system ... recording using a standard 12-lead setup ... The software includes two applications: Rest ...
Medicine Products: